SCHEMBL29913633

SCHEMBL29913633

Brc1c(Br)c2ccc3ccc4ccc5ccc6ccc1c1c6c5c4c3c21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.35
HPGD P15428 4/20 0.35
HSD17B10 Q99714 3/20 0.35
CYP1A2 P05177 3/20 0.35
CYP3A4 P08684 2/20 0.35
TSHR P16473 2/20 0.35
CYP1A1 P04798 1/20 0.35
CYP1B1 Q16678 1/20 0.35
TDP1 Q9NUW8 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
THRB P10828 1/20 0.33
POLB P06746 1/20 0.32
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
MAPT P10636 1/20 0.31
APEX1 P27695 1/20 0.31
RECQL P46063 1/20 0.31
BLM P54132 1/20 0.31
KMT2A Q03164 1/20 0.31
ERBB2 P04626 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13146030 1.00 ALDH1A1 (0.35) ALDH1A1HPGDHSD17B10CYP1A2CYP3A4
SCHEMBL27943944 0.92 ALDH1A1 (0.30) ALDH1A1HPGDHSD17B10CYP1A2CYP3A4
SCHEMBL30300160 0.92 ALDH1A1 (0.30) ALDH1A1HPGDHSD17B10CYP1A2CYP3A4
SCHEMBL30300410 0.92 ALDH1A1 (0.30) ALDH1A1HPGDHSD17B10CYP1A2CYP3A4
SCHEMBL28659812 0.80 HSD17B10 (0.50) ALDH1A1HPGDHSD17B10CYP1A2CYP3A4
SCHEMBL4585407 0.78 ALDH1A1 (0.55) ALDH1A1HPGDHSD17B10CYP1A2CYP3A4
SCHEMBL25361772 0.78 KDM4E (0.32) ALDH1A1HPGDTDP1KDM4EMEN1
SCHEMBL28244803 0.77 ALDH1A1 (0.62) ALDH1A1HPGDHSD17B10CYP1A2CYP3A4
SCHEMBL5474368 0.76 ALDH1A1 (0.45) ALDH1A1HPGDHSD17B10CYP1A2CYP3A4
SCHEMBL5477100 0.76 ALDH1A1 (0.45) ALDH1A1HPGDHSD17B10CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250137126-A1 GRAPHENE COATED METALLIC SURFACES, DEVICES AND METHOD OF MANUFACTURE THEREOF BAR-ILAN UNIVERSITY (IL) 2025-05-01 US disclosed
WO-2023042210-A1 GRAPHENE COATED METALLIC SURFACES, DEVICES AND METHOD OF MANUFACTURE THEREOF 2D GENERATION LTD. (IL) 2023-03-23 WO disclosed
US-11499093-B2 Rare earth complex and light emitting element NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) 2022-11-15 US disclosed
CN-110337441-B Rare earth complex and light-emitting element 国立大学法人北海道大学 2022-09-06 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11499093-B2 Rare earth complex and light emitting element LAGE3, UACA, COIL ALDH1A1 2854/4885HPGD 4183/4885HSD17B10 2894/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.